Ryan C. Heniford/LinkedIn
Oct 14, 2025, 05:26
Ryan C. Heniford: Every Thrombus Prevented Is a Patient Protected
Ryan C. Heniford, Director of Global Business Development and Technical Marketing at Evonik, shared a post on LinkedIn:
”Today is World Thrombosis Day! A reminder that thrombosis prevention isn’t just about medication, it’s also about smarter medical devices.
That’s where Evonik’s Endexo technology comes in.
It’s an innovative passive surface modification that makes catheter surfaces inherently more biocompatible — no coatings, no drugs, no leaching.
Key benefits at a glance:
- Up to 99 % reduction in thrombus accumulation
- Less protein and platelet adhesion → reduced clot risk
- Lower friction for smoother handling and less trauma
- Durable performance because Endexo® is part of the polymer itself
On World Thrombosis Day, it’s worth remembering that every thrombus prevented is a patient protected — and that innovation in materials science plays a crucial role in that.”
Stay updated with Hemostasis Today.
-
Jan 14, 2026, 11:16ISTH 2026: Laurent Bertoletti To Serve as Vice Theme Leader for VTE
-
Jan 14, 2026, 11:08Leni von Bonsdorff Invites You to Hear and Learn The Latest News in The Plasma Field
-
Jan 14, 2026, 05:56Arun V J on The “Whole Blood” Nostalgia Trap
-
Jan 13, 2026, 16:38Caitlin Raymond: Understanding TAMOF as a TTP-Like Process
-
Jan 13, 2026, 15:22John Amako: Childhood to Adulthood Management Approach for SCD
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels